semaglutide glp-1 analogue Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns Is GLP-1 Safe for Weight

Evaluating drug cost per responder and number needed to treat associated with lixisenatide on top of glargine when compared to rapid-acting insulin intensification regimens on top of glargine, in patients with type 2 diabetes in the UK, Italy, and Spain

thaliana and its mutants displaying enhanced disease susceptibility (Reuber et al., 1998)

The greater amount of melanin in our skin helps absorb and block UV rays

Importantly, chronic peripheral antagonism of the GLP-1R for one week produced additional food intake and weight gain in high-fat dietfed obese mice (4)

Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies

Sales hit $2.35 billion in 2025, up 59% year over year, but analysts expect growth to moderate sharply in 2026 to around 16%